RxDoctor Payments Data

Anthony Stover, DO

Family Medicine · Orlando, FLNPI 1619381894

Payments from drug & device makers

$1,870in general payments, 2019–2025

Across 98 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$485
  • Novo Nordisk$338
  • AbbVie$168
  • Lilly USA, LLC$130
  • Exact Sciences$122
  • GSK$113
  • plus $513 from 11 others

What the payments were for

  • Food & beverage$1,85599%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,870 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$136,093
Medicare patients
408
Services billed
1,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban142$162,579
OzempicSemaglutide81$126,798
XareltoRivaroxaban33$40,004
FarxigaDapagliflozin Propanediol31$30,634
MounjaroTirzepatide20$26,421
JardianceEmpagliflozin14$20,404
InvokanaCanagliflozin18$16,908
LinzessLinaclotide11$16,114
Repatha SureclickEvolocumab15$13,456
EntrestoSacubitril/Valsartan14$12,549
Breo ElliptaFluticasone/Vilanterol12$8,077
SynthroidLevothyroxine Sodium84$7,069
SymbicortBudesonide/Formoterol Fumarate13$6,982
Rosuvastatin Calcium482$6,729
Atorvastatin Calcium466$4,970

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$485$163,971155 claims
Novo NordiskOzempic$338$126,79881 claims
Johnson & JohnsonXarelto, Invokana$47$56,91251 claims
AstraZenecaFarxiga, Symbicort$68$37,61644 claims
Lilly USA, LLCMounjaro$130$26,42120 claims
AbbVieLinzess, Synthroid$168$23,18495 claims
NovartisEntresto$36$12,54914 claims
GSKBreo Ellipta, Arnuity Ellipta$113$10,82025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →